Chrissi Hatzoglou
Overview
Explore the profile of Chrissi Hatzoglou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
327
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jagirdar R, Rouka E, Pitaraki E, Sarrigeorgiou I, Kotsiou O, Sinis S, et al.
Am J Physiol Lung Cell Mol Physiol
. 2024 Oct;
328(1):L105-L112.
PMID: 39470611
Malignant pleural mesothelial cells are affected by the extracellular milieu although such data on benign cells are scarce. Benign cells sense the extracellular environment with the primary cilium (PC) and...
2.
Jagirdar R, Grammatikopoulos A, Ioannou M, Solenov E, Gourgoulianis K, Hatzoglou C, et al.
In Vivo
. 2024 Aug;
38(5):2294-2299.
PMID: 39187341
Background/aim: Cigarette smoke has been shown to induce a phenotype in humans known as "acquired cystic fibrosis". This occurs because the cystic fibrosis transmembrane conductance regulator (CFTR) functions are impaired...
3.
Pitaraki E, Jagirdar R, Rouka E, Bartosova M, Sinis S, Gourgoulianis K, et al.
Biochem Biophys Res Commun
. 2023 Dec;
693:149376.
PMID: 38104523
Peritoneal dialysis (PD) and prolonged exposure to PD fluids (PDF) induce peritoneal membrane (PM) fibrosis and hypervascularity, leading to functional PM degeneration. 2-deoxy-glucose (2-DG) has shown potential as PM antifibrotic...
4.
Giannopoulos A, Giannakou L, Gourgoulianni N, Pitaraki E, Jagirdar R, Marnas P, et al.
Environ Toxicol Pharmacol
. 2023 Nov;
104:104325.
PMID: 37995887
Drosophila melanogaster is a widely used animal model in human diseases and to date it has not been applied to the study of the impact of tobacco use on human...
5.
Rouka E, Zarogiannis S, Hatzoglou C, Gourgoulianis K, Malli F
Biomolecules
. 2023 Sep;
13(9).
PMID: 37759718
Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) is a carboxypeptidase B-like proenzyme encoded by the gene. After thrombin activation, TAFI downregulates fibrinolysis, thus linking the latter with coagulation. TAFI has been shown to...
6.
Rouka E, Jagirdar R, Sarrigeorgiou I, Pitaraki E, Sinis S, Varsamas C, et al.
Pharmacol Rep
. 2023 Aug;
75(5):1230-1239.
PMID: 37542187
Background: Malignant pleural mesothelioma (MPM), a rare and aggressive pleural tumor, has significant histological and molecular heterogeneity. Primary Cilium (PC), an organelle of emerging importance in malignancies, has been scarcely...
7.
Jagirdar R, Pitaraki E, Kotsiou O, Rouka E, Sinis S, Varsamas C, et al.
Biochem Biophys Res Commun
. 2023 Mar;
654:128-135.
PMID: 36907140
Introduction: Primary cilium (PC) is a single non-motile antenna-like organelle composed of a microtubule core axon originating from the mother centriole of the centrosome. The PC is universal in all...
8.
Giannakou L, Giannopoulos A, Hatzoglou C, Gourgoulianis K, Rouka E, Zarogiannis S
Pathophysiology
. 2022 Apr;
28(1):20-33.
PMID: 35366267
(), () and () are three of the most common gram-negative bacteria responsible for human respiratory diseases. In this study, we aimed to identify, using the functional enrichment analysis (FEA),...
9.
K Symvoulakis E, Karageorgiou I, Linardakis M, Papagiannis D, Hatzoglou C, Symeonidis A, et al.
Healthcare (Basel)
. 2022 Mar;
10(3).
PMID: 35327023
The aim of this study was to investigate the knowledge, attitudes, and practices of primary care physicians and residents towards the COVID-19 pandemic in Greece. A cross-sectional questionnaire-based study was...
10.
Adamou A, Giannopoulos A, Arvaniti C, Belios I, Dalampira D, Eleftheriadis G, et al.
Sleep Sci
. 2022 Mar;
15(Spec 1):105-109.
PMID: 35273754
Obstructive Sleep Apnea Syndrome (OSAS) is a chronic disease that significantly increases morbidity and mortality of the affected population. There is lack of data concerning the OSAS prevalence in the...